特拉維爾治療公司
US ˙ NasdaqGM ˙ US89422G1076

簡介

本頁面提供了有關 Elizabeth E Reed 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Elizabeth E Reed已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:TVTX / Travere Therapeutics, Inc. Chief Legal Officer and GC 105,211
US:CLDN / Celladon Corp VP, General Counsel 142,500
如何解讀這些圖表

以下圖表顯示了在Elizabeth E Reed進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

TVTX / Travere Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 TVTX / Travere Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

TVTX / Travere Therapeutics, Inc. Insider Trades
TVTX / Travere Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 TVTX / Travere Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2026-05-05 TVTX REED ELIZABETH E 2,174 46.6500 2,174 46.6500 101,417 14 42.2600 -9,544 -9.41
2026-04-14 TVTX REED ELIZABETH E 7,215 41.9288 7,215 41.9288 302,516
2026-02-03 TVTX REED ELIZABETH E 7,175 32.1200 7,175 32.1200 230,461
2024-02-01 TVTX REED ELIZABETH E 2,174 8.5317 2,174 8.5317 18,548
2021-08-17 TVTX REED ELIZABETH E 1,407 17.1187 1,407 17.1187 24,086
2020-09-23 RTRX REED ELIZABETH E 1,500 18.4800 1,500 18.4800 27,720
2020-09-22 RTRX REED ELIZABETH E 1,500 18.5900 1,500 18.5900 27,885
2020-05-12 RTRX REED ELIZABETH E 527 16.9843 527 16.9843 8,951
2018-01-05 RTRX REED ELIZABETH E 942 24.0400 942 24.0400 22,646

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

TVTX / Travere Therapeutics, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Elizabeth E Reed 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2026-05-06 2026-05-06 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,076 105,211 -1.93 43.95 -91,240 4,624,023
2026-05-06 2026-05-05 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale -2,174 107,287 -1.99 46.65 -101,417 5,004,939
2026-05-06 2026-05-04 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 4,250 109,461 4.04
2026-05-06 2026-05-04 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -20,000 105,211 -15.97 45.00 -900,000 4,734,495
2026-05-06 2026-05-04 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 20,000 125,211 19.01 17.96 359,200 2,248,790
2026-04-15 2026-04-15 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -1,559 105,211 -1.46 42.53 -66,304 4,474,624
2026-04-15 2026-04-15 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -5,226 106,770 -4.67 41.62 -217,506 4,443,767
2026-04-15 2026-04-14 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale -7,215 111,996 -6.05 41.93 -302,516 4,695,858
2026-04-15 2026-04-14 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -37,500 119,211 -23.93 41.07 -1,540,125 4,895,996
2026-04-15 2026-04-14 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 7,500 156,711 5.03 15.46 115,950 2,422,752
2026-04-15 2026-04-14 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 20,000 149,211 15.48 17.96 359,200 2,679,830
2026-04-15 2026-04-14 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 10,000 129,211 8.39 19.08 190,800 2,465,346
2026-04-15 2026-04-13 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 14,000 119,211 13.31
2026-04-02 2026-04-01 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -10,000 105,211 -8.68 30.00 -300,000 3,156,330
2026-04-02 2026-04-01 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 10,000 115,211 9.50 15.46 154,600 1,781,162
2026-03-18 2026-03-16 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -10,000 105,211 -8.68 28.09 -280,861 2,954,967
2026-03-18 2026-03-16 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 10,000 115,211 9.50 19.08 190,800 2,198,226
2026-02-19 2026-02-17 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -4,321 105,211 -3.94 28.26 -122,120 2,973,473
2026-02-19 2026-02-17 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -5,679 109,532 -4.93 27.50 -156,195 3,012,568
2026-02-19 2026-02-17 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 10,000 115,211 9.50 19.08 190,800 2,198,226
2026-02-05 2026-02-04 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -509 105,211 -0.48 32.74 -16,665 3,444,608
2026-02-05 2026-02-04 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,485 105,720 -2.30 32.07 -79,694 3,390,440
2026-02-03 2026-02-03 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale -7,175 108,205 -6.22 32.12 -230,461 3,475,545
2026-02-03 2026-01-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 25,110 115,380 27.82
2026-01-21 2026-01-20 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -10,000 90,270 -9.97 27.34 -273,420 2,468,162
2026-01-21 2026-01-20 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 10,000 100,270 11.08 19.08 190,800 1,913,152
2025-09-24 2025-09-22 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -10,000 89,878 -10.01 25.00 -250,000 2,246,950
2025-09-24 2025-09-22 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 10,000 99,878 11.13 19.08 190,800 1,905,672
2025-05-05 2025-05-05 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -4,920 89,482 -5.21 21.05 -103,566 1,883,596
2025-05-05 2025-05-02 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 4,920 94,402 5.50
2025-02-12 2025-02-12 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -8,000 89,482 -8.21 23.53 -188,240 2,105,511
2025-02-12 2025-02-10 4 TVTX Travere Therapeutics, Inc.
Common Stock 		M - Exercise 8,000 97,482 8.94
2025-02-04 2025-02-03 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -8,951 89,482 -9.09 19.78 -177,051 1,769,954
2025-02-04 2025-01-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 21,500 98,433 27.95
2025-01-23 2025-01-22 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,437 76,933 -3.07 19.46 -47,424 1,497,116
2024-09-09 2024-09-09 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -4,387 78,633 -5.28 11.52 -50,538 905,852
2024-09-09 2024-09-05 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 6,750 83,020 8.85
2024-02-02 2024-02-01 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,590 76,270 -3.28 8.86 -22,947 675,752
2024-02-02 2024-02-01 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale -2,174 78,860 -2.68 8.53 -18,548 672,810
2024-02-02 2024-01-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 25,000 81,034 44.62
2024-01-25 2024-01-23 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,062 56,034 -3.55 8.96 -18,476 502,065
2023-09-05 2023-09-05 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -1,815 58,096 -3.03 14.71 -26,699 854,592
2023-09-05 2023-08-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 3,300 59,911 5.83
2023-05-12 2023-05-10 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -825 56,611 -1.44 16.59 -13,687 939,176
2023-02-02 2023-02-01 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,590 57,436 -4.31 22.25 -57,628 1,277,951
2023-02-02 2023-01-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 20,250 60,026 50.91
2023-01-26 2023-01-24 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,062 39,776 -4.93 21.50 -44,333 855,184
2022-05-12 2022-05-12 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -1,050 41,838 -2.45 21.51 -22,584 899,894
2022-05-12 2022-05-10 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -900 42,888 -2.06 21.51 -19,359 922,521
2022-02-02 2022-01-31 4 TVTX Travere Therapeutics, Inc.
Performance-based restricted stock units 		A - Award 8,000 8,000
2022-02-02 2022-01-31 4 TVTX Travere Therapeutics, Inc.
Performance-based restricted stock units 		A - Award 9,840 9,840
2022-02-02 2022-01-31 4 TVTX Travere Therapeutics, Inc.
Employee stock option (right to buy) 		A - Award 39,360 39,360
2022-02-02 2022-01-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -1,350 43,788 -2.99 27.40 -36,990 1,199,791
2022-02-02 2022-01-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 9,840 45,138 27.88
2022-01-26 2022-01-24 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,250 35,298 -5.99 24.98 -56,205 881,744
2022-01-12 2022-01-11 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -5,000 37,548 -11.75 27.40 -137,000 1,028,815
2022-01-12 2022-01-10 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 5,000 42,548 13.32
2021-08-17 2021-08-17 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale -1,407 37,548 -3.61 17.12 -24,086 642,773
2021-08-17 2021-08-13 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 4,500 38,955 13.06
2021-05-13 2021-05-12 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -1,625 34,455 -4.50 19.46 -31,622 670,494
2021-05-13 2021-05-11 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -1,625 36,080 -4.31 19.14 -31,102 690,571
2021-02-09 2021-02-08 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,250 37,705 -5.63 31.58 -71,055 1,190,724
2021-02-09 2021-02-05 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,250 39,955 -5.33 31.41 -70,672 1,254,987
2021-02-05 2021-02-03 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 4,500 42,205 11.93
2021-02-03 2021-02-03 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -675 37,705 -1.76 28.91 -19,514 1,090,052
2021-02-03 2021-02-03 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,500 38,380 -6.12 28.91 -72,275 1,109,566
2021-02-02 2021-02-02 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -675 40,880 -1.62 30.75 -20,756 1,257,060
2021-02-02 2021-02-02 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,500 41,555 -5.67 30.75 -76,875 1,277,816
2021-02-02 2021-01-31 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 5,000 44,055 12.80
2021-01-25 2021-01-21 4 TVTX Travere Therapeutics, Inc.
Employee stock option (right to buy) 		A - Award 57,500 57,500
2021-01-25 2021-01-21 4 TVTX Travere Therapeutics, Inc.
Common Stock 		A - Award 15,000 39,055 62.36
2021-01-07 2021-01-06 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -688 24,055 -2.78 27.01 -18,583 649,726
2021-01-07 2021-01-05 4 TVTX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -688 24,743 -2.71 26.65 -18,335 659,401
2020-11-17 2020-11-16 4 RTRX Travere Therapeutics, Inc.
Common Stock 		S - Sale X -2,500 25,431 -8.95 23.98 -59,950 609,835
2020-11-13 2020-11-13 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -2,500 27,931 -8.22 23.62 -59,046 659,680
2020-11-13 2020-11-11 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 5,000 30,431 19.66
2020-09-23 2020-09-23 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale -1,500 25,431 -5.57 18.48 -27,720 469,965
2020-09-22 2020-09-22 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale -1,500 26,931 -5.28 18.59 -27,885 500,647
2020-09-22 2020-09-18 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 3,000 28,431 11.80
2020-05-13 2020-05-12 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale -527 25,431 -2.03 16.98 -8,951 431,928
2020-05-13 2020-05-12 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -525 25,958 -1.98 17.16 -9,009 445,439
2020-05-13 2020-05-11 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -525 26,483 -1.94 14.95 -7,849 395,921
2020-03-12 2020-03-10 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -3,500 27,008 -11.47 15.02 -52,570 405,660
2020-03-09 2020-03-05 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 3,500 30,508 12.96
2020-01-31 2020-01-31 4 RTRX Retrophin, Inc.
Performance-based restricted stock units 		A - Award 10,000 10,000
2020-01-31 2020-01-31 4 RTRX Retrophin, Inc.
Performance-based restricted stock units 		A - Award 9,000 9,000
2020-01-31 2020-01-31 4 RTRX Retrophin, Inc.
Employee stock option (right to buy) 		A - Award 55,000 55,000
2020-01-31 2020-01-31 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 9,000 27,008 49.98
2020-01-08 2020-01-08 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -750 18,008 -4.00 15.14 -11,355 272,641
2020-01-08 2020-01-07 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -750 18,758 -3.84 13.94 -10,455 261,487
2019-05-16 2019-05-15 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -525 19,508 -2.62 17.71 -9,298 345,487
2019-05-16 2019-05-14 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -525 20,033 -2.55 17.75 -9,319 355,586
2019-05-10 2019-05-09 4 RTRX Retrophin, Inc.
Performance-based restricted stock units 		A - Award 6,000 6,000
2019-05-10 2019-05-09 4 RTRX Retrophin, Inc.
Employee stock option (right to buy) 		A - Award 40,000 40,000
2019-05-10 2019-05-09 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 6,000 20,558 41.21
2019-02-13 2019-02-12 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -884 14,558 -5.72 21.50 -19,006 312,997
2019-02-13 2019-02-11 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -885 15,442 -5.42 21.38 -18,921 330,150
2019-01-09 2019-01-09 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -750 16,327 -4.39 23.82 -17,865 388,909
2019-01-09 2019-01-08 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -750 17,077 -4.21 24.09 -18,068 411,385
2018-11-16 2018-11-15 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -100 17,827 -0.56 24.80 -2,480 442,199
2018-11-16 2018-11-15 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -100 17,927 -0.55 24.77 -2,477 444,052
2018-11-16 2018-11-15 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -2,300 18,027 -11.31 24.29 -55,858 437,809
2018-11-16 2018-11-14 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -300 20,327 -1.45 24.57 -7,371 499,434
2018-11-16 2018-11-14 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale X -2,200 20,627 -9.64 23.62 -51,959 487,162
2018-11-14 2018-11-09 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 5,000 22,827 28.05
2018-05-14 2018-05-10 4 RTRX Retrophin, Inc.
Performance-based restricted stock units 		A - Award 7,000 7,000
2018-05-14 2018-05-10 4 RTRX Retrophin, Inc.
Employee stock option (right to buy) 		A - Award 42,000 42,000
2018-05-14 2018-05-10 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 7,000 17,827 64.65
2018-02-12 2018-02-08 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 1,769 10,827 19.53
2018-01-08 2018-01-05 4 RTRX Retrophin, Inc.
Common Stock 		S - Sale -942 9,058 -9.42 24.04 -22,646 217,754
2017-01-06 2017-01-04 4 RTRX Retrophin, Inc.
Employee Stock Options (Right to Buy) 		A - Award 50,000 50,000
2017-01-06 2017-01-04 4 RTRX Retrophin, Inc.
Common Stock 		A - Award 10,000 10,000
2015-01-05 2015-01-01 4 CLDN Celladon Corp
Stock option (right to buy) 		A - Award 72,000 142,500 102.13
2014-06-11 2014-06-09 4 CLDN Celladon Corp
Stock option (right to buy) 		A - Award 65,000 65,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）